Zobrazeno 1 - 10
of 87
pro vyhledávání: '"inhibitor 9"'
Autor:
Frontiers Editorial Office
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Externí odkaz:
https://doaj.org/article/aeb1047354834ddf994037f3cb4d469e
Autor:
Stanislava Reinstein Merjava, Jan Kossl, Ales Neuwirth, Pavlina Skalicka, Zuzana Hlinomazova, Vladimir Holan, Katerina Jirsova
Publikováno v:
Biology, Vol 11, Iss 5, p 793 (2022)
The aim of this study was to find out whether protease inhibitor 9 (PI-9) and granzyme B (GrB) molecules that contribute to immune response and the immunological privilege of various tissues are expressed in healthy and pathological human corneas. Us
Externí odkaz:
https://doaj.org/article/ccd648f1c8b14e428cf3d5abb60036e1
Autor:
Jiayu Liu, Yongbo Zheng, Yingying Gao, Zhen Quan, Bo Qiao, Luo Li, Ting Li, Limei Duan, Jinxiao Yang, Chunli Luo, Xiaohou Wu
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Castration-resistant prostate cancer (CRPC) is a progressed stage of prostate cancer, which requires better understanding of the mechanisms and remains an unmet clinical need. As a common oncogene, K-Ras is associated with malignant behavior in diffe
Externí odkaz:
https://doaj.org/article/313f7147e29c42a2bea8decd07d9c3c0
Autor:
Goshi Shiota, Hiroyuki Tsuchiya
Publikováno v:
Tsuchiya, Hiroyuki. Shiota, Goshi. Immune evasion by cancer stem cells. Regenerative Therapy. 17. 20-33. doi:10.1016/j.reth.2021.02.006
Regenerative Therapy, Vol 17, Iss, Pp 20-33 (2021)
Regenerative Therapy
Regenerative Therapy, Vol 17, Iss, Pp 20-33 (2021)
Regenerative Therapy
Tumor immunity represents a new avenue for cancer therapy. Immune checkpoint inhibitors have successfully improved outcomes in several tumor types. In addition, currently, immune cell-based therapy is also attracting significant attention. However, t
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Renza Vento, Cesare Cernigliaro, Michela Giuliano, Daniela Carlisi, Marianna Lauricella, Giuseppe Calvaruso, Antonella D'Anneo
Breast cancer stem cells seem to play important roles in breast tumor recurrence and endocrine therapy resistance, although the underlying mechanisms have not been well established. Moreover, in some tumor systems the immunosurveillance failure again
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b980d63567f847d93c36b11fb108498
http://hdl.handle.net/10447/183022
http://hdl.handle.net/10447/183022
Autor:
LAURICELLA, Marianna, CARLISI, Daniela, GIULIANO, Michela, CALVARUSO, Giuseppe, CERNIGLIARO, CESARE, D'ANNEO, Antonella
Breast cancer (BC) is the most common endocrine cancer and the second leading cause of cancer-related death in women. About 75% of BCs expresses high levels of estrogen receptors that sustain the tumor growth. Moreover, in BC estrogens prevent apopto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::16646a0501ca9074e5269f5f2281a4e1
https://www.ibim.cnr.it/homebiotec
https://www.ibim.cnr.it/homebiotec
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1451(2-3):233-241
Proteinase inhibitor PI9 (PI9) is an intracellular 42-kDa member of the ovalbumin family of serpins that is found primarily in placenta, lung and lymphocytes. PI9 has been shown to be a fast-acting inhibitor of granzyme B in vitro, presumably through
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.